期刊文献+

肾病综合征鼠骨代谢变化特点及芪归合剂对其的作用 被引量:1

Change of Bone Metabolism in Rats with Nephrotic Syndrome and the Role of Astragalus and Angelica Mixture
下载PDF
导出
摘要 目的探讨肾病综合征(NS)鼠骨代谢的变化特点及芪归合剂对其的作用。方法制备大鼠阿霉素NS模型,设模型组、激素治疗组、芪归治疗组、激素芪归治疗组及正常对照组,每组8只,用药时间为3周。测量各组尿蛋白、血生化指标和右股骨长度;用HologicQDR-2000+DEXA行股骨全段骨密度(BMD)测定;以放射免疫法测定血清骨钙素(OC)、I型前胶原氨基端伸展肽(PINP)、I型胶原羧基端关联肽原(ICTP)水平。结果模型组股骨长度(3.35±0.09)cm,低于正常组(3.53±0.11)cm(P<0.05);芪归治疗组(3.46±0.09)cm,高于模型组(P<0.05);激素芪归组(3.28±0.07)cm,高于激素治疗组(3.16±0.11)cm(P<0.01);激素治疗组低于模型组(P<0.05)。模型组股骨全段BMD(0.1357±0.0137)g/㎝2,低于正常组(0.1599±0.0101)g/㎝2(P<0.01);激素治疗组(0.1208±0.0123)g/㎝2,低于模型组(P<0.05)。模型组血OC(16.31±3.87)μg/L和PINP(2.02±0.51)μg/L水平,低于正常组,分别(31.49±4.16)μg/L、(3.58±0.46)μg/L(P<0.01);芪归治疗组血OC(25.90±8.26)μg/L和PINP(3.42±1.07)μg/L水平,高于模型组(分别P<0.05和P<0.01);激素芪归组血OC(12.01±1.97)μg/L和PINP(2.47±0.88)μg/L水平,高于激素治疗组,分别(6.12±3.26)μg/L、(1.63±0.74)μg/L(P<0.05);激素治疗组低于模型组(P<0.05)。激素治疗组的ICTP(10.15±3.77)μg/L高于模型组(8.71±3.29)μg/L(P<0.05)。结论NS鼠存在骨代谢的异常,激素治疗使骨代谢异常进一步加剧,而芪归合剂治疗对其有改善作用。 [Objective] To investigate the change of bone metabolism in rats with nephrotic syndrome (NS) and the role of Astragalus and Angelica mixture (A&A). [ Methods] Forty male SD rats (six weeks old) were randomly divided into five groups: control group, NS model group, NS group treated with A&A, NS group treated with dexamethasone (Dex), NS group treated with A&A and Dex. Urine protein, serum biochemical levels and the femur length were measured. The bone mineral density (BMD) of whole part of femur was measured by Hologic ODR-2000+DEXA. Serum osteocalcin (OC), aminoterminal propeptide of type Ⅰ procollagen (PINP) and carboxytenninal telopeptide of type Ⅰ collagen (ICTP) levels were assayed by radioimmunoassay technique. [Results] The length of femur of NS group treated with A&A and NS group treated with A&A and Dex were higher than those in NS model group and NS group treated with Dex, respectively (P 〈 0.05 and P 〈 0.05). The length of femur of NS group treated with Dex was lower than that of NS model group (P 〈 0.05). The length of femur of NS model group was lower than that of control group (P 〈 0.05). The BMD of femur in NS model group was lower than that of control group (P 〈 0.01). The serum levels of OC and PINP in NS model group were lower than those in control group (P 〈 0.01). The serum levels of OC and PINT in NS group treated with A&A and NS group treated with A&A and Dex were higher than those in NS model group and NS group treated with Dex, respectively (P 〈 0.05 and P 〈 0.01,respectively). The serum levels of OC and PINP in NS group treated with Dex were lower than those in NS model group (P 〈 0.05). The serum levels of ICTP in NS group treated with Dex were higher than that of NS model group (P 〈 0.05).[Conclusion] The abnormality of bone metabolism exists in nephrotic rats. Dexamethasone treatment can aggravate this abnormality, which can be improved by Astragalus and Angelica mixture.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2006年第1期67-71,共5页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省卫生厅科研基金资助项目(A2003168) 广东省自然科学基金博士启动基金资助项目(04300346)
关键词 肾病综合征 骨代谢 黄芪 当归 nephrotic syndrome bone metabolism astragalus angelica
  • 相关文献

参考文献9

二级参考文献9

  • 1Jaffe EA. Culture of human endothelial cells. Transplant Proc 1980, 12(3 suppl 1):49--53.
  • 2Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science,1989 ;246(4935) : 1306--1309.
  • 3Rosenstein JM, Mani N, Silverman WF, et al. Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. Proc Natl Acad Sci USA,1998;95(12) : 7086--7091.
  • 4Vaisman N, Gospodarowicz D, Neufeld G. Characterization of the receptors for vascular endothelial growth factor. J Biol Chem 1990;265(32):19461--19466.
  • 5Keyt BA, Nguyen HV, Berleau LT, et al. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J Biol Chem 1996;271(10):5638--5646.
  • 6袁敏敏,宋美芳,高怡.骨吸收三种尿生化指标的敏感性比较[J].临床检验杂志,1998,16(4):232-233. 被引量:4
  • 7盛琴慧,周爱儒,高炜,朱国英.多肽生长因子与血管生成[J].中国介入心脏病学杂志,1999,7(2):90-92. 被引量:4
  • 8俞雷,李惊子,洪健美,蔡松敏,王海燕.黄芪当归合剂降低肾病综合征大鼠血脂机制的探讨[J].中华肾脏病杂志,1999,15(6):337-339. 被引量:122
  • 9戴瑞鸿,李勇.冠心病心肌缺血的治疗性血管生成与中医药[J].中国中西医结合杂志,2000,20(3):163-164. 被引量:40

共引文献125

同被引文献15

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部